165 related articles for article (PubMed ID: 35506275)
1. Research progress on the role of fibroblast activation protein in diagnosis and treatment of cancer.
Wu Z; Hua Y; Shen Q; Yu C
Nucl Med Commun; 2022 Jul; 43(7):746-755. PubMed ID: 35506275
[TBL] [Abstract][Full Text] [Related]
2. Effects of the fibroblast activation protein on the invasion and migration of gastric cancer.
Wang RF; Zhang LH; Shan LH; Sun WG; Chai CC; Wu HM; Ibla JC; Wang LF; Liu JR
Exp Mol Pathol; 2013 Dec; 95(3):350-56. PubMed ID: 24422232
[TBL] [Abstract][Full Text] [Related]
3. Specific inhibition of fibroblast activation protein (FAP)-alpha prevents tumor progression in vitro.
Teichgräber V; Monasterio C; Chaitanya K; Boger R; Gordon K; Dieterle T; Jäger D; Bauer S
Adv Med Sci; 2015 Sep; 60(2):264-72. PubMed ID: 26057860
[TBL] [Abstract][Full Text] [Related]
4. Clinical summary of fibroblast activation protein inhibitor-based radiopharmaceuticals: cancer and beyond.
Li M; Younis MH; Zhang Y; Cai W; Lan X
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2844-2868. PubMed ID: 35098327
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast heterogeneity in solid tumors: From single cell analysis to whole-body imaging.
Peltier A; Seban RD; Buvat I; Bidard FC; Mechta-Grigoriou F
Semin Cancer Biol; 2022 Nov; 86(Pt 3):262-272. PubMed ID: 35489628
[TBL] [Abstract][Full Text] [Related]
6.
Giesel FL; Kratochwil C; Lindner T; Marschalek MM; Loktev A; Lehnert W; Debus J; Jäger D; Flechsig P; Altmann A; Mier W; Haberkorn U
J Nucl Med; 2019 Mar; 60(3):386-392. PubMed ID: 30072500
[TBL] [Abstract][Full Text] [Related]
7. Theranostics Targeting Fibroblast Activation Protein in the Tumor Stroma:
Watabe T; Liu Y; Kaneda-Nakashima K; Shirakami Y; Lindner T; Ooe K; Toyoshima A; Nagata K; Shimosegawa E; Haberkorn U; Kratochwil C; Shinohara A; Giesel F; Hatazawa J
J Nucl Med; 2020 Apr; 61(4):563-569. PubMed ID: 31586001
[TBL] [Abstract][Full Text] [Related]
8. Photoimmunotherapy for cancer-associated fibroblasts targeting fibroblast activation protein in human esophageal squamous cell carcinoma.
Watanabe S; Noma K; Ohara T; Kashima H; Sato H; Kato T; Urano S; Katsube R; Hashimoto Y; Tazawa H; Kagawa S; Shirakawa Y; Kobayashi H; Fujiwara T
Cancer Biol Ther; 2019; 20(9):1234-1248. PubMed ID: 31185791
[TBL] [Abstract][Full Text] [Related]
9. From basic research to clinical application: targeting fibroblast activation protein for cancer diagnosis and treatment.
Zhang Z; Tao J; Qiu J; Cao Z; Huang H; Xiao J; Zhang T
Cell Oncol (Dordr); 2024 Apr; 47(2):361-381. PubMed ID: 37726505
[TBL] [Abstract][Full Text] [Related]
10. Molecular recognition of fibroblast activation protein for diagnostic and therapeutic applications.
Šimková A; Bušek P; Šedo A; Konvalinka J
Biochim Biophys Acta Proteins Proteom; 2020 Jul; 1868(7):140409. PubMed ID: 32171757
[TBL] [Abstract][Full Text] [Related]
11. Expression of the FAP gene in non-fibroblast human cell lines. Development of cancer-associated fibroblast models.
Tyulkina DV; Pleshkan VV; Alekseenko IV; Kopantseva MR; Sverdlov ED
Dokl Biochem Biophys; 2016 Sep; 470(1):319-321. PubMed ID: 27817025
[TBL] [Abstract][Full Text] [Related]
12. Theranostics in targeting fibroblast activation protein bearing cells: Progress and challenges.
Rezaei S; Gharapapagh E; Dabiri S; Heidari P; Aghanejad A
Life Sci; 2023 Sep; 329():121970. PubMed ID: 37481033
[TBL] [Abstract][Full Text] [Related]
13. Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein.
Lindner T; Loktev A; Altmann A; Giesel F; Kratochwil C; Debus J; Jäger D; Mier W; Haberkorn U
J Nucl Med; 2018 Sep; 59(9):1415-1422. PubMed ID: 29626119
[TBL] [Abstract][Full Text] [Related]
14. IDH-wildtype glioblastomas and grade III/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein-specific PET/CT.
Röhrich M; Loktev A; Wefers AK; Altmann A; Paech D; Adeberg S; Windisch P; Hielscher T; Flechsig P; Floca R; Leitz D; Schuster JP; Huber PE; Debus J; von Deimling A; Lindner T; Haberkorn U
Eur J Nucl Med Mol Imaging; 2019 Nov; 46(12):2569-2580. PubMed ID: 31388723
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast activation protein-α-expressing fibroblasts promote the progression of pancreatic ductal adenocarcinoma.
Kawase T; Yasui Y; Nishina S; Hara Y; Yanatori I; Tomiyama Y; Nakashima Y; Yoshida K; Kishi F; Nakamura M; Hino K
BMC Gastroenterol; 2015 Sep; 15():109. PubMed ID: 26330349
[TBL] [Abstract][Full Text] [Related]
16. Development of Fibroblast Activation Protein-Targeted Radiotracers with Improved Tumor Retention.
Loktev A; Lindner T; Burger EM; Altmann A; Giesel F; Kratochwil C; Debus J; Marmé F; Jäger D; Mier W; Haberkorn U
J Nucl Med; 2019 Oct; 60(10):1421-1429. PubMed ID: 30850501
[TBL] [Abstract][Full Text] [Related]
17. FAP Delineates Heterogeneous and Functionally Divergent Stromal Cells in Immune-Excluded Breast Tumors.
Cremasco V; Astarita JL; Grauel AL; Keerthivasan S; MacIsaac K; Woodruff MC; Wu M; Spel L; Santoro S; Amoozgar Z; Laszewski T; Migoni SC; Knoblich K; Fletcher AL; LaFleur M; Wucherpfennig KW; Pure E; Dranoff G; Carroll MC; Turley SJ
Cancer Immunol Res; 2018 Dec; 6(12):1472-1485. PubMed ID: 30266714
[TBL] [Abstract][Full Text] [Related]
18. Advancement and Future Perspective of FAPI PET/CT In Gynecological Malignancies.
Dendl K; Koerber SA; Tamburini K; Mori Y; Cardinale J; Haberkorn U; Giesel FL
Semin Nucl Med; 2022 Sep; 52(5):628-634. PubMed ID: 35842334
[TBL] [Abstract][Full Text] [Related]
19. The Latest Developments in Imaging of Fibroblast Activation Protein.
Altmann A; Haberkorn U; Siveke J
J Nucl Med; 2021 Feb; 62(2):160-167. PubMed ID: 33127618
[TBL] [Abstract][Full Text] [Related]
20. Antitumor effects of chimeric receptor engineered human T cells directed to tumor stroma.
Kakarla S; Chow KK; Mata M; Shaffer DR; Song XT; Wu MF; Liu H; Wang LL; Rowley DR; Pfizenmaier K; Gottschalk S
Mol Ther; 2013 Aug; 21(8):1611-20. PubMed ID: 23732988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]